This issue is part two of a two-part issue involving the emerging field of stem cell transplantation.  Articles include: BMT for profound T cell Dysfunction (combined immunodeficiency); BMT and other management of HLA Class II deficiency; Genetic manipulation of stem cells - Past and future; Gene therapy for ADA deficiency; Haemopoietic stem cell biology; and Indications for BMT.